Home News Page 66

News

CytomX’s Antibody Therapies Target Cancer, Leave Healthy Tissue Intact

Antibody technology holds promise for treating a wide array of diseases, and designing new antibodies is a hot area...

Total Antibody Quantification for MMAE-Conjugated Antibody-Drug Conjugates: Impact of Assay Format and Reagents

The use of antibody drug conjugates (ADCs) as targeted chemotherapies has successfully entered clinical practice and holds great promise....

The Analytical and Bioanalytical Technologies for Characterizing Antibody-drug Conjugates

Antibody-drug conjugates (ADCs) require multiple assays for analytical and bioanalytical characterization due to their heterogeneous and dynamic nature. These...

Astellas, Ambrx seal $300M cancer ADC deal

Astellas Pharma has wagered on antibody drug conjugate tech from the San Diego biotech startup Ambrx, paying $15 million...

Design and Efficacy of Antibody-drug Conjugates in Oncology

The use of antibody drug conjugates (ADCs) as targeted chemotherapies has successfully entered clinical practice and holds great promise....

Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand

Lonza today announced plans to invest CHF 14 million to expand Antibody Drug Conjugate (ADC) manufacturing capacity in Visp,...

Celgene wraps $500M deal to partner with Sutro on next-gen ADCs Read more: Celgene...

Antibody-drug conjugates are hot. Next-gen ADCs are even hotter. So Celgene has turned to the upstart ADC developers at...

Intellect Neurosciences Awards Future Development and Manufacture of the Antibody-drug Conjugate CONJUMAB-A to Lonza.

Lonza announced today that Intellect Neurosciences, Inc. awarded the future development and manufacture of the antibody drug conjugate CONJUMAB-A...

Researchers Develop Antibody-drug Conjugate Technology for Hematologic Disorders

Antibody-drug conjugates (ADCs) combine cytotoxic chemotherapy and antibody specificity. There are 4 components of ADC technology: the cancer, or...

Genmab and Lonza Enter in Development and Manufacturing Agreement for HuMax-TF™ – A Novel...

Lonza announces a new development and manufacturing agreement with Genmab A/S. This agreement secures a development and cGMP manufacturing...

FEATURED RESOURCES